Literature DB >> 647437

Prostaglandin PGE2: a possible mechanism for bone destruction in calcinosis circumscripta.

A Caniggia, C Gennari, A Vattimo, F Runci, S Bombardieri.   

Abstract

A patient showed evident osteolysis in phalanges and heavy periarticular calcium deposits of the fingers, wrists and toes which avidly took up 47Ca. The dense, white, tooth-paste like fluid contained in the periarticular calcium deposits has been studied by two different X-ray diffraction methods, by Ubatuba's bioassay for prostaglandin, by thin layer chromatography and by mass spectrometry. The calcium deposits were hydroxyapatite and prostaglandin PGE2 was detected in them. The bone resorption stimulating activity of PGE2 would be expected to result in increased bone destruction with release of calcium salts and this could be a working hypothesis of the pathogenesis of calcinosis circumscripta.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647437     DOI: 10.1007/BF02010751

Source DB:  PubMed          Journal:  Calcif Tissue Res        ISSN: 0008-0594


  11 in total

1.  Letter: Indomethacin-responsive hypercalcemia.

Authors:  H Ito; T Sanada; T Katayama; J Shimazaki
Journal:  N Engl J Med       Date:  1975-09-11       Impact factor: 91.245

2.  Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.

Authors:  R P Robertson; D J Baylink; B J Marini; H W Adkison
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

3.  [Method for the measurement of the principal routes of calcium metabolism in man].

Authors:  J P AUBERT; G MILHAUD
Journal:  Biochim Biophys Acta       Date:  1960-03-25

4.  Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.

Authors:  E F Voelkel; A H Tashjian; R Franklin; E Wasserman; L Levine
Journal:  Metabolism       Date:  1975-08       Impact factor: 8.694

5.  Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.

Authors:  H D Brereton; P V Halushka; R W Alexander; D M Mason; H R Keiser; V T DeVita
Journal:  N Engl J Med       Date:  1974-06-11       Impact factor: 91.245

6.  Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma.

Authors:  A H Tashjian; E F Voelkel; P Goldhaber; L Levine
Journal:  Prostaglandins       Date:  1973-04

7.  Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin.

Authors:  L Levine; P M Hinkle; E F Voelkel; A H Tashjian
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

8.  The use of the hamster stomach in vitro as an assay preparation for prostaglandins.

Authors:  F B Ubatuba
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

9.  Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis.

Authors:  D R Robinson; A H Tashjian; L Levine
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.